685 - 696 of 7279 results
1 CME CREDIT

In the second episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the risks to healthcare workers associated with COVID-19. They will review current data on systems-based solutions to reduce transmission risk, the importance of personal protective equipment (PPE), and when to discontinue precautions in patients with resolved COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/09/2020, and they are subject to change as new information is published.


1 CME CREDIT

In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.


1 CME CREDIT

1 CME CREDIT

In the sixth episode of Pri-Med’s weekly web series on COVID-19, faculty will interview a patient who recently recovered from COVID-19. This patient will share his experience from diagnosis to recovery, including thoughts on his interaction with the healthcare system during this unique time. This session aims to give clinicians a better understanding of the patient perspective, and helps us recognize where there is potential for improvement in caring for patients with COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/07/2020 and they are subject to change as new information is published.


1 CME CREDIT

In the seventh episode of Pri-Med’s weekly web series on COVID-19, faculty will start off a multi-episode spanning discussion on COVID-19 treatment by analyzing recent evidence of antiviral therapies. They will also review the current recommendations regarding their use in patients with COVID-19. Therapies to be discussed in this episode will include: • Convalescent Plasma • Camostat Mesilate • Lopinavir/Ritonavir • Hydroxychloroquine and Chloroquine • Remdesivir Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/14/2020 and they are subject to change as new information is published.


PrimaryCareNOW: Recorded Live on May 8, 2020

5.00 CME/MOC
5.00 AANP | 0.79 Pharmacology


1 CME CREDIT

Are you ready to be quizzed on dizziness? In this live recording of a Jeopardy style game, you can watch faculty ask and answer questions related to important topics in neurology! The faculty will provide a rationale following each question, ensuring that you have answers to take back to your practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on Nov. 1, 2019 and they are subject to change as new information is published.


0.75 CME CREDIT

Are you ready to be quizzed on dizziness? In this live recording of a Jeopardy style game, you can watch faculty ask and answer questions related to important topics in neurology! The faculty will provide a rationale following each question, ensuring that you have answers to take back to your practice. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on Nov. 1, 2019 and they are subject to change as new information is published.


This program will highlight a different approach to the treatment of heart failure with reduced ejection fraction (HFrEF). By targeting a mechanism of action aligned to pathophysiologic pathways, it is possible to reduce patient mortality and morbidity, while providing a proven safety and tolerability profile to help provide confidence in selecting your first-choice therapy for patients with HFrEF.


Join us as we examine the risk of hospitalization for heart failure (HF) among patients with type 2 diabetes (T2D) and explore evidence-based risk reduction strategies that you can incorporate into your practice. We will discuss the results of the DECLARE trial, the largest cardiovascular (CV) outcomes trial to study hospitalization for HF reduction in patients with T2D and established CV disease or multiple CV risk factors. We'll also discuss the results of the landmark DAPA-HF trial that support FARXIGA being the FIRST and ONLY FDA-approved sodium-glucose cotransporter 2 inhibitor (SGLT2) for patients with HF with reduced ejection fraction (HFrEF) with and without T2D.


1 CME CREDIT

During this virtual expert roundtable, faculty will discuss the diagnosis and management of migraine, with focus on treatment options for acute treatment to help you select effective and appropriate treatments for your patients on an individualized basis. They will describe newer classes of medications that have recently been approved for acute migraine treatment and compare with older options for acute treatment. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 6/26/2020 and they are subject to change as new information is published.